Mostrar el registro sencillo del ítem

dc.contributor.authorRojas Segovia, Alejandra María 
dc.contributor.authorMoreira Soares, Adriana
dc.contributor.authorMendoza Torres, Laura Patricia 
dc.contributor.authorAcosta de Hetter, María Eugenia 
dc.contributor.authorAria, Laura Silvana 
dc.contributor.authorPáez Acchiardi, Gloria Malvina 
dc.contributor.authorHerebia, Lilian
dc.contributor.authorVallejos, María Asunción
dc.contributor.authorArévalo de Guillén, Ivalena 
dc.contributor.authorAquino Quintana, Víctor Hugo 
dc.date.accessioned2024-03-04T21:33:13Z
dc.date.available2024-03-04T21:33:13Z
dc.date.issued2021-08-07
dc.identifier.citationRojas, A., Moreira Soares, A., Mendoza, L.P. et al. Revisiting the dengue epidemic of 2011 in Paraguay: molecular epidemiology of dengue virus in the Asuncion metropolitan area. BMC Infect Dis 21, 769 (2021). https://doi.org/10.1186/s12879-021-06487-9en
dc.identifier.otherhttps://doi.org/10.1186/s12879-021-06487-9es
dc.identifier.urihttp://hdl.handle.net/20.500.14066/4379
dc.descriptionCorrespondence: vhugo@fcfrp.usp.bren
dc.description.abstractBackground. Dengue is one of the most important re-emerging viral diseases and the most common human arthropod-borne viral infection worldwide. Any of the four Dengue virus serotypes (DENV-1 to 4) can cause asymptomatic infections or clinical manifestations that range in severity from a mild, self-limited illness, to a severe disease characterized by a shock syndrome that can lead to death. Paraguay suffers periodic epidemic outbreaks of dengue since 1988 when the DENV-1 was introduced in the country. Epidemics caused by all four serotypes have been reported and the country. Although dengue is endemic in Paraguay, few studies have described the molecular epidemiology of DENV in the country, which is important to understand the local and global spread, as well as the evolution of this pathogen. Methods. This was a cross-sectional study of a convenience sample. Suspected dengue patients of any age were recruited from the Emergency Laboratory of the Central Hospital of the Institute of Social Welfare, Asuncion, Paraguay, from February to June of 2011. A DENV antigen test was used to confirm the infection. The protein E gene sequences of isolated viruses were sequenced for phylogenetic analysis. Results. Dengue was confirmed in 55.1% of the participants (n = 98/178). The most frequent clinical findings were fever, headache, and myalgia. Identity analyses of the protein E gene sequence of 56 viruses isolated showed the circulation of DENV-1 (n = 45) and DENV-2 (n = 11) in the Asuncion metropolitan area in 2011. Molecular epidemiology analyses suggest that DENV-1 was introduced into Paraguay from Argentina, while the DENV-2 from Brazil, replacing previous virus lineages. Conclusions. We have analyzed the molecular epidemiology of DENV-1 and DENV-2 isolated in Paraguay in 2011. We found strong evidence that DENV-1 was introduced into Paraguay from Argentina, while the DENV-2 from Brazil, replacing previous virus lineages. Molecular epidemiology studies are of great interest to analyze the dynamic of DENV spread, which are useful for early implementation of containment measures to reduce the risk of explosive epidemics caused by this virus.es
dc.description.sponsorshipConsejo Nacional de Ciencia y Tecnologíaes
dc.format.extent10 páginases
dc.language.isoenges
dc.publisherSpringer Naturees
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.classification7. Saludes
dc.subject.otherDengue viruses
dc.subject.otherEnvelope glycoproteines
dc.subject.otherGenetic diversityes
dc.subject.otherMolecular epidemiologyes
dc.subject.otherPhylogenetic relationshipes
dc.titleRevisiting the dengue epidemic of 2011 in Paraguay : molecular epidemiology of dengue virus in the Asuncion metropolitan areaes
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.doi10.1186/s12879-021-06487-9es
dc.description.fundingtextPrograma de Apoyo al Desarrollo de la Ciencia, Tecnología e Innovaciónes
dc.identifier.essn1471-2334es
dc.journal.titleBMC Infectious Diseaseses
dc.relation.projectCONACYTBID 1698/OC-PR Nº 50/2010es
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.rights.copyright© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.es


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

  • Artículos científicos
    La colección comprende artículos científicos, revisiones y artículos de conferencia que son resultados de actividades de I+D financiadas por el Programa PROCIENCIA.

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional